![Terrie Curran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Terrie Curran
Director/Board Member at
ARCUTIS BIOTHERAPEUTICS, INC.
Net worth: 4 M $ as of 31/05/2026
Profile
Ms. Terrie Curran is an Independent Director at Arcutis Biotherapeutics, Inc. She is on the Board of Directors at Arcutis Biotherapeutics, Inc. and Roivant Sciences, Inc. Ms. Curran was previously employed as a President, Chief Executive Officer & Director by Phathom Pharmaceuticals, Inc., an Independent Director by Myovant Sciences Ltd., an Independent Director by H.
Lundbeck A/S, a President-Global Inflammation & Immunology by Celgene Corp., a SVP & GM-Global Women's Health by Merck & Co., Inc., and a General Manager by Schering-Plough Corp.
She also served on the board at BioNJ, Inc. She received her undergraduate degree from the University of Technology Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/03/2026 | 389,860 ( 0.49% ) | 4 M $ | 31/05/2026 | |
| 05/06/2026 | 17,748 ( 0.01% ) | 380 872 $ | 31/05/2026 |
Terrie Curran active positions
| Companies | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 02/11/2020 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Director/Board Member | - |
Former positions of Terrie Curran
| Companies | Position | End |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Chief Executive Officer | 31/03/2025 |
| MYOVANT SCIENCES LTD. | Director/Board Member | 10/03/2023 |
| CELGENE | Corporate Officer/Principal | 01/09/2019 |
| H. LUNDBECK A/S | Director/Board Member | 01/03/2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2013 |
Training of Terrie Curran
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Technology Sydney
 University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Terrie Curran
